Literature DB >> 18716305

Human papillomavirus vaccination--reasons for caution.

Charlotte J Haug.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716305     DOI: 10.1056/NEJMe0804638

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Controlling cervical cancer.

Authors:  Maurizio Bonati; Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Cancer in the shadow of the AIDS epidemic in southern Africa.

Authors:  Julie Livingston
Journal:  Oncologist       Date:  2013

Review 3.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397

4.  Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.

Authors:  Leah M Smith; Jay S Kaufman; Erin C Strumpf; Linda E Lévesque
Journal:  CMAJ       Date:  2014-12-08       Impact factor: 8.262

5.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

Review 6.  Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma.

Authors:  Liviu Feller; Neil H Wood; Razia A G Khammissa; Johan Lemmer
Journal:  Head Face Med       Date:  2010-07-15       Impact factor: 2.151

7.  Modeling and molecular dynamics of the intrinsically disordered e7 proteins from high- and low-risk types of human papillomavirus.

Authors:  Nilson Nicolau; Silvana Giuliatti
Journal:  J Mol Model       Date:  2013-07-18       Impact factor: 1.810

8.  Prevalence of human papillomavirus infection in women in Benin, West Africa.

Authors:  Franca Piras; Michela Piga; Antonella De Montis; Ahissou R F Zannou; Luigi Minerba; Maria T Perra; Daniela Murtas; Manuela Atzori; Marco Pittau; Cristina Maxia; Paola Sirigu
Journal:  Virol J       Date:  2011-11-10       Impact factor: 4.099

9.  Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.

Authors:  Eric J Suba; Stephen S Raab
Journal:  Diagn Cytopathol       Date:  2011-03-10       Impact factor: 1.582

Review 10.  Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV.

Authors:  Simona Di Mario; Vittorio Basevi; Pier Luigi Lopalco; Sara Balduzzi; Roberto D'Amico; Nicola Magrini
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.